Detection of different hypoxic cell subpopulations in human melanoma xenografts by pimonidazole immunohistochemistry

Radiation Research

Volumn 170, Issue 5, 2008, Pages 638-650

  Gulliksrud, Kristine ^a   Vestvik, Ida K ^a   Galappathi, Kanthi ^a   Mathiesen, Berit ^a   Rofstad, Einar K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFFIN; PIMONIDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CANCER CYTODIAGNOSIS; CELL FRACTIONATION; CELL LABELING; CELL SUBPOPULATION; FEMALE; FROZEN SECTION; HEMOPERFUSION; HYPOXIC CELL; IMMUNOHISTOCHEMISTRY; MELANOMA; MOUSE; NONHUMAN; OXYGEN DIFFUSION; PRIORITY JOURNAL; RADIATION DOSE; RADIOBIOLOGY; STAINING; TUMOR CELL; XENOGRAFT;

ANIMALS; CELL HYPOXIA; FEMALE; FROZEN SECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NITROIMIDAZOLES; PARAFFIN EMBEDDING; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 55549089640     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1400.1     Document Type: Article

References (29)

1. P. Vaupel, Tumor microenvironmental physiology and its implications for radiation oncology. Semin. Radiat. Oncol. 14, 198-206 (2004).
2. E. K. Rofstad, Microenvironment-induced cancer metastasis. Int. J. Radiat. Biol. 76, 589-605 (2000).
3. M. Höckel and P. Vaupel, Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst. 93, 266-276 (2001).
4. J. M. Brown and A. J. Giaccia, The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 58, 1408-1416 (1998).
5. R. E. Durand and E. Sham, The lifetime of hypoxic human tumor cells. Int. J. Radiat. Oncol. Biol. Phys. 42, 711-715 (1998).
6. A. S. E. Ljungkvist, J. Bussink, J. H. A. M. Kaanders, P. F. J. W. Rijken, A. C. Begg, J. A. Raleigh and A. J. van der Kogel, Hypoxic cell turnover in different solid tumor lines. Int. J. Radiat. Oncol. Biol. Phys. 62, 1157-1168 (2005).
7. M. W. Dewhirst, Concepts of oxygen transport at the microcirculatory level. Semin. Radiat. Oncol. 8, 143-150 (1998).
8. K. L. Bennewith and R. E. Durand, Quantifying transient hypoxia in human tumor xenografts by flow cytometry. Cancer Res. 64, 6183-6189 (2004).
9. M. R. Horsman, Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. Acta Oncol. 34, 571-587 (1995).
10. A. S. E. Ljungkvist, J. Bussink, J. H. A. M. Kaanders and A. J. van der Kogel, Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers. Radiat. Res. 167, 127-145 (2007).
11. E. K. Rofstad, Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern. Br. J. Cancer 70, 804-812 (1994).
12. E. K. Rofstad and K. Ma° seide, Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours. Int. J. Radiat. Biol. 75, 1377-1393 (1999).
13. E. K. Rofstad, Influence of cellular radiation sensitivity on local tumor control of human melanoma xenografts given fractionated radiation treatment. Cancer Res. 51, 4609-4612 (1991).
14. E. K. Rofstad, A. Wahl, C. L. Davies and T. Brustad, Growth characteristics of human melanoma multicellular spheroids in liquid-overlay culture: comparisons with the parent tumour xenografts. Cell Tissue Kinet. 19, 205-216 (1986).
15. J. A. Raleigh, S. C. Chou, G. E. Arteel and M. R. Horsman, Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat. Res. 151, 580-589 (1999).
16. C. Azuma, J. A. Raleigh and D. E. Thrall, Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime. Radiat. Res. 148, 35-42 (1997).
17. A. S. Kennedy, J. A. Raleigh, G. M. Perez, D. P. Calkins, D. E. Thrall, D. B. Novotny and M. A. Varia, Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. Int. J. Radiat. Oncol. Biol. Phys. 37, 897-905 (1997).
18. P. L. Olive, R. E. Durand, J. A. Raleigh, C. Luo and C. Aquino-Parsons, Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia. Br. J. Cancer 83, 1525-1531 (2000).
19. A. Yaromina, T. Hölscher, W. Eicheler, A. Rosner, M. Krause, F. Hessel, C. Petersen, H. D. Thames, M. Baumann and D. Zips, Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma. Radiother. Oncol. 76, 206-212 (2005).
20. K. L. Bennewith, J. A. Raleigh and R. E. Durand, Orally administered pimonidazole to label hypoxic tumor cells. Cancer Res. 62, 6827-6830 (2002).
21. 2 fluctuations in human melanoma xenografts. Int. J. Radiat. Oncol. Biol. Phys. 58, 403-409 (2004).
22. R. E. Durand and N. E. LePard, Contribution of transient blood flow to tumour hypoxia in mice. Acta Oncol. 34, 317-323 (1995).
23. H. Kimura, R. D. Braun, E. T. Ong, R. Hsu, T. W. Secomb, D. Papahadjopoulos, K. Hong and M. W. Dewhirst, Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res. 56, 5522-5528 (1996).
24. L. I. Cárdenas-Navia, D. Yu, R. D. Braun, D. M. Brizel, T. W. Secomb and M. W. Dewhirst, Tumor-dependent kinetics of partial pressure of oxygen fluctuations during air and oxygen breathing. Cancer Res. 64, 6010-6017 (2004).
25. 2 in poorly and well-oxygenated spontaneous canine tumors before and during fractionated radiation therapy. Radiother. Oncol. 77, 220-226 (2005).
26. 2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study. Radiother. Oncol. 80, 123-131 (2006).
27. R. A. Cairns, T. Kalliomäki and R. P. Hill, Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res. 61, 8903-8908 (2001).
28. R. A. Cairns and R. P. Hill, Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma. Cancer Res. 64, 2054-2061 (2004).
29. E. K. Rofstad, K. Galappathi, B. Mathiesen and E. B. M. Ruud, Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis. Clin. Cancer Res. 13, 1971-1978 (2007).